Related references
Note: Only part of the references are listed.
Article
Oncology
Randomized multicenter phase II study of larotaxel (XRP9881) in combination with cisplatin or gemcitabine as first-line chemotherapy in nonirradiable stage IIIB or stage IV non-small cell lung cancer
Petr Zatloukal et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Share Paper
